Nomura Asset Management CO LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $0 - $0	0 New	0 $0
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $0 - $0	0 New	0 $0
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $179,940 - $327,699	-6,475 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$58.09 - $82.51 $376,132 - $534,252	6,475 New	6,475 $429,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $378,010 - $550,116	-6,475 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$61.35 - $90.47 $397,241 - $585,793	6,475 New	6,475 $429,000
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $0 - $0	0 New	0 $0

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.